Cargando…

Teratoma Assay for Testing Pluripotency and Malignancy of Stem Cells: Insufficient Reporting and Uptake of Animal-Free Methods—A Systematic Review

Pluripotency describes the ability of stem cells to differentiate into derivatives of the three germ layers. In reporting new human pluripotent stem cell lines, their clonal derivatives or the safety of differentiated derivatives for transplantation, assessment of pluripotency is essential. Historic...

Descripción completa

Detalles Bibliográficos
Autores principales:	Montilla-Rojo, Joaquin, Bialecka, Monika, Wever, Kimberley E., Mummery, Christine L., Looijenga, Leendert H. J., Roelen, Bernard A. J., Salvatori, Daniela C. F.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9967860/ https://www.ncbi.nlm.nih.gov/pubmed/36835305 http://dx.doi.org/10.3390/ijms24043879

Ejemplares similares

Humanised Mice and Immunodeficient Mice (NSG) Are Equally Sensitive for Prediction of Stem Cell Malignancy in the Teratoma Assay
por: Bialecka, Monika, et al.
Publicado: (2022)

The MicroRNA-371 Family as Plasma Biomarkers for Monitoring Undifferentiated and Potentially Malignant Human Pluripotent Stem Cells in Teratoma Assays
por: Salvatori, Daniela C.F., et al.
Publicado: (2018)

Differentiation-Defective Human Induced Pluripotent Stem Cells Reveal Strengths and Limitations of the Teratoma Assay and In Vitro Pluripotency Assays
por: Bouma, Marga J., et al.
Publicado: (2017)

Standardization of the Teratoma Assay for Analysis of Pluripotency of Human ES Cells and Biosafety of Their Differentiated Progeny
por: Gropp, Michal, et al.
Publicado: (2012)

Murine pluripotent stem cells that escape differentiation inside teratomas maintain pluripotency
por: Pei, Yangli, et al.
Publicado: (2018)

Reporting of anaesthesia and pain management in preclinical large animal models of articular cartilage repair - A long way to go
por: Fugazzola, Maria C., et al.
Publicado: (2022)

Mediastinal teratoma with hydrops fetalis in a newborn and development of chronic respiratory insufficiency
por: Simoncic, Milanka, et al.
Publicado: (2014)

Preventing Pluripotent Cell Teratoma in Regenerative Medicine Applied to Hematology Disorders
por: Bedel, Aurelie, et al.
Publicado: (2016)

Cisplatin induces differentiation in teratomas derived from pluripotent stem cells
por: Kurata, Atsushi, et al.
Publicado: (2021)

Attenuation of teratoma formation by p27 overexpression in induced pluripotent stem cells
por: Matsu-ura, Toru, et al.
Publicado: (2016)

Defining the Skeletal Myogenic Lineage in Human Pluripotent Stem Cell-Derived Teratomas
por: Pappas, Matthew P., et al.
Publicado: (2022)

Immunoreactivity of Pluripotent Markers SSEA-5 and L1CAM in Human Tumors, Teratomas, and Induced Pluripotent Stem Cells
por: Cassidy, Linda, et al.
Publicado: (2013)

Intrapulmonary mature Teratoma
por: Saini, Monika Lamba, et al.
Publicado: (2006)

Inflammatory Responses and Barrier Function of Endothelial Cells Derived from Human Induced Pluripotent Stem Cells
por: Halaidych, Oleh V., et al.
Publicado: (2018)

DNA methylation and transcriptional trajectories during human development and reprogramming of isogenic pluripotent stem cells
por: Roost, Matthias S., et al.
Publicado: (2017)

Accurate primary germ cell cancer diagnosis using serum based microRNA detection (ampTSmiR test)
por: van Agthoven, Ton, et al.
Publicado: (2016)

In vivo reprogrammed pluripotent stem cells from teratomas share analogous properties with their in vitro counterparts
por: Choi, Hyun Woo, et al.
Publicado: (2015)

Perspectives on the Use of Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes in Biomedical Research
por: Mummery, Christine L.
Publicado: (2018)

Pharmacological modulation of conditioned fear in the fear-potentiated startle test: a systematic review and meta-analysis of animal studies
por: Groenink, Lucianne, et al.
Publicado: (2023)

Conditionally replicating adenovirus prevents pluripotent stem cell–derived teratoma by specifically eliminating undifferentiated cells
por: Mitsui, Kaoru, et al.
Publicado: (2015)

Reversible transformation and de-differentiation of human cells derived from induced pluripotent stem cell teratomas
por: Kamada, Mizuna, et al.
Publicado: (2015)

Comparison of Magnetic Resonance Imaging and Serum Biomarkers for Detection of Human Pluripotent Stem Cell-Derived Teratomas
por: Riegler, Johannes, et al.
Publicado: (2016)

TeratoScore: Assessing the Differentiation Potential of Human Pluripotent Stem Cells by Quantitative Expression Analysis of Teratomas
por: Avior, Yishai, et al.
Publicado: (2015)

Photodynamic Approach for Teratoma-Free Pluripotent Stem Cell Therapy Using CDy1 and Visible Light
por: Cho, Seung-Ju, et al.
Publicado: (2016)

Natural Killer Cells Prevent the Formation of Teratomas Derived From Human Induced Pluripotent Stem Cells
por: Benabdallah, Basma, et al.
Publicado: (2019)

The Chromatin Regulator ZMYM2 Restricts Human Pluripotent Stem Cell Growth and Is Essential for Teratoma Formation
por: Lezmi, Elyad, et al.
Publicado: (2020)

Primary Teratoma of the Lesser Sac: Lesser Sac Teratoma
por: Hardesty, Brandon M., et al.
Publicado: (2012)

Gluteal teratoma: A rare site of extragonadal teratoma
por: Dutta, Hemonta Kr., et al.
Publicado: (2016)

Intracranial monodermal teratoma presenting with growing teratoma syndrome
por: Khoo, B., et al.
Publicado: (2017)

Growing teratoma syndrome secondary to ovarian immature teratoma
por: Campo-Rivera, Natalia, et al.
Publicado: (2020)

Predicting Gonadal Germ Cell Cancer in People with Disorders of Sex Development; Insights from Developmental Biology
por: Looijenga, Leendert H. J., et al.
Publicado: (2019)

Designing, conducting, and reporting reproducible animal experiments
por: Wilson, Emma, et al.
Publicado: (2023)

Characterization of migratory primordial germ cells in the aorta-gonad-mesonephros of a 4.5-week-old human embryo: a toolbox to evaluate in vitro early gametogenesis
por: Gomes Fernandes, Maria, et al.
Publicado: (2018)

Repair of Ischemic Injury by Pluripotent Stem Cell Based Cell Therapy without Teratoma through Selective Photosensitivity
por: Cho, Seung-Ju, et al.
Publicado: (2015)

Lysine-specific demethylase 1 inhibitors prevent teratoma development from human induced pluripotent stem cells
por: Osada, Naoki, et al.
Publicado: (2018)

Prunellae Spica Extract Suppresses Teratoma Formation of Pluripotent Stem Cells through p53-Mediated Apoptosis
por: Kim, Aeyung, et al.
Publicado: (2020)

Teratoma Models
por: Evans, M. J.
Publicado: (1980)

Sacrococcygeal teratoma
por: Srivastava, Arun, et al.
Publicado: (2010)

Teratoma of the tongue
por: Gupta, S, et al.
Publicado: (2012)

Oral teratoma
por: Kolekar, Shreesh S, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_jkfj38gfc7tdi85vv94kiq0fuf